Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

16th World Cardiology Congress

Dubai, UAE

Omar Kamel Hallak

Omar Kamel Hallak

American Hospital Dubai, UAE

Title: New oral anticoagulants for stroke prevention in atrial fibrillation

Biography

Biography: Omar Kamel Hallak

Abstract

Atrial Fibrillation is one of the most common arrhythmia in adults and  it is one of the major cause of Stroke. The stroke due to Atrial Fibrillation (AF) usually more sever comparing with other etiologies .

Warferin has been the gold stander medication to prevent stroke in AF patients With success rate about 65%. However, warfarin has many drawbacks:  it has unpredictable response, narrow therapeutic window , slow  onset/offset action, many interactions with food and medication, need continues monitoring .with about 50% only in the therapeutic range.

New Oral anticoagulants (NOAC) which became approved few years ago, have faster onset/offset action, no need for monitoring, less interaction with food and medication . several randomize studies confirm that NOAC is as effective as Warfarin or even more effective in some case, and it is safer and more convenient to use . however it is much more expensive .

The clinical application and practical aspect of their usage will be discuss further during the presentation